Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-11

Clinical Trial Update: Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating on-demand combination therapy of dapoxetine with tadalafil or with lidocaine 5% spray for lifelong premature ejaculation in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • dapoxetine + lidocaine 5% spray (on-demand) (lidocaine)
  • dapoxetine + tadalafil (on-demand)

Snippet

Sponsor: Sohag University | Conditions: Premature Ejaculation | Phase 3 | Status: UNKNOWN